Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment. [electronic resource]
Producer: 20111221Description: 375-8 p. digitalISSN:- 1439-0973
- Aged
- Amphotericin B -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Antiprotozoal Agents -- therapeutic use
- Bone Marrow -- parasitology
- Fatal Outcome
- Female
- Humans
- Immunocompromised Host
- Italy
- Leishmania infantum -- drug effects
- Leishmaniasis, Visceral -- blood
- Leukocytes, Mononuclear -- parasitology
- Lymphoma, Non-Hodgkin -- drug therapy
- Polymerase Chain Reaction
- Polymorphism, Restriction Fragment Length
- Recurrence
- Rituximab
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.